Currently, the therapeutic agents used clinically to treat osteoporosis are selective estrogen receptor modulators (SERMs), Denosumab (anti-RANKL antibody), bisphosphonates, parathyroid hormone, and health supplements including calcium and vitamin D (Cranney et al., 2002; Zur et al., 2018). Here, TNFSF11 is linked to osteoporosis.